Value Bridge — JOHN RANDOLPH MEDICAL CENTER
Current $10M → Target $12M (+$2.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$9.5M
Current EBITDA
$12.2M
Target EBITDA
+$2.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.6M
Payer Mix Optimization
$1.4M
Cost to Collect Reduction
$0.5M
Clean Claim Improvement
$0.4M
Volume & Rate Growth
$2.4M
What This Means
The 7-lever model projects a 28% EBITDA uplift from $10M to $12M. The highest-impact lever is Volume & Rate Growth at $1.0M probability-weighted.
IC talking point: "We see $3M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $29M in equity value creation."